Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

DeLauro Renews Push To Give FDA Mandatory Recall Authority For Drugs

Jan 12 2020

• By Malcolm Spicer

Washington DC Capitol dome detail with waving american flag

Related Content

DeLauro, Durbin Reheat Proposal For Separate Food Safety Agency

Feb 02 2015

More Asbestos-Linked Makeup Recalls Ring Regulatory Legislation Bell Again

Jun 11 2019

FDA Finds Ranitidine Poses Little Risk, But Concerns Linger

Nov 04 2019

OTC Zantac And Private Label Ranitidine Numerous In FDA Recall Updates

Jan 12 2020

Online Pharmacy Stirs Ranitidine Controversy With Petition To Halt Sales

Sep 15 2019

Contamination In Common OTC Antacid Adds To FDA's API Impurity Concerns

Sep 15 2019

'Mock' Recalls Suggested, But US FDA Isn't Joking About Recalling Products

Apr 24 2019

Las Vegas Kratom Marketer Rolls Dice On FDA's Mandatory Recall Authority

Apr 03 2018

Additional Topics

United States US States OTC Drugs Legislation Recalls Advertising, Marketing & Sales Commercial Companies Compliance Drug Safety Enforcement FDA Ingredients Manufacturing Policy Regulation Safety Consumer

More from Legislation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window